For the past two decades, the outlook for individuals suffering from Multiple System Atrophy (MSA) has been nothing short of dismal. This rare and progressive neurodegenerative disorder, often misdiagnosed as Parkinson’s disease, has left many patients and their families facing a future marked by debilitating symptoms and limited treatment options. Continue reading